In vitro processing with cryopreservation of bone marrow or peripheral blood, for autologous stem cell transplantation for a patient receiving high‑dose chemotherapy for management of: (a) aggressive malignancy; or (b) malignancy that has proven refractory to prior treatment (H)
In vitro processing with cryopreservation of bone marrow or peripheral blood, for autologous stem cell transplantation for a patient receiving high‑dose chemotherapy for management of: (a) aggressive malignancy; or (b) malignancy that has proven refractory to prior treatment (H)
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $889.65 | $912.8 |
| March 2026 | UPDATED | $889.65 | $889.65 |
Data sourced from Australian Government publications · Not an official government service